Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of doripenem (S-4661) in pediatric meningitis and other bacterial infections
jRCT2080221492Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of doripenem in bacterial meningitis and bacterial disease, sponsored by Shionogi & Co., Ltd.
02
Drugs
doripenem
03
Conditions
bacterial meningitisbacterial disease
Beyond the preview
Go deeper on jRCT2080221492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221492.